Undecimal Bio: €16 Million to Advance Targeted RNA Medicines
Undecimal Bio is a Cambridge-based biotechnology company developing targeted delivery technologies for RNA medicines. Spun out of Eleven Therapeutics, the company is addressing a major challenge in RNA therapeutics: delivering a treatment to the intended cells and tissues rather than relying on the therapeutic molecule alone. Small interfering RNA (siRNA) can be used to silence … Leer más